Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2010
03/18/2010WO2009125447A3 Treatment for the hair regrowth in the bald patches formed by alopecia of the celsi area
03/18/2010WO2008154898A3 Preparation for the treatment of equine laminitis
03/18/2010US20100071079 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
03/18/2010US20100069510 Process for the manufacture of a powder containing carotenoids
03/18/2010US20100069495 Topical application of adapalene for the long-term treatment of acne vulgaris
03/18/2010US20100069491 Lipid-amino acid conjugates and methods of use
03/18/2010US20100069476 Compositions and methods for reduction of cutaneous photoageing
03/18/2010US20100069473 Inhibitors Of IKK-Beta Serine-Threonine Protein Kinase
03/18/2010US20100069454 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
03/18/2010US20100069444 Phenathrenone compounds, compositons and methods
03/18/2010US20100069386 Modulators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069338 Pharmaceutical compositions
03/18/2010US20100069323 Composition for application to skin or mucosa
03/18/2010US20100069311 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
03/18/2010US20100068310 External composition for skin containing scrophularia buergeriana miq. extract and the use thereof for the skin moisturizing cosmetics
03/18/2010US20100068307 Dermatological emulsion and method for the preparation thereof
03/18/2010US20100068279 Burn bandage
03/18/2010US20100068259 Natural product inhibitors of 3dg
03/18/2010US20100068247 Method And System For Providing Targeted And Individualized Delivery Of Cosmetic Actives
03/18/2010US20100068245 Preparation and storage of stable, biologically active materials
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068162 Compositions Having Silicone Properties
03/18/2010CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds
03/17/2010EP2163557A1 Function-selective vitamin d receptor agonist
03/17/2010EP2163554A1 Pyrimidodiazepinone derivative
03/17/2010EP2163546A1 Quinazoline derivatives
03/17/2010EP2163254A1 Use of HGF for the manufacture of a medicament for treating fibrotic disorders
03/17/2010EP2163245A1 Renin inhibitors for the treatment of psoriasis
03/17/2010EP2162140A2 Highly stable electrolytic water with reduced nmr half line width
03/17/2010EP1503729B1 Composition and the use thereof as a pharmaceutical or cosmetic formulation for external use
03/17/2010EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use
03/17/2010CN101675059A Macrocyclic compound
03/17/2010CN101674841A Anti-histamine substance and method for production thereof
03/17/2010CN101674808A Polyaphron topical composition with vitamin d and corticosteroid
03/17/2010CN101671393A Angiopoietin-2 specific binding agents
03/17/2010CN101670044A Medicine for curing gestational chloasma and preparation method thereof
03/17/2010CN101670040A Liquid medicine for treating hair loss
03/17/2010CN101670036A External aloe vera dry jelly powder patch used for trauma wound
03/17/2010CN101670019A Complex preparation having radiation-resisting and eyesight-protecting functions
03/17/2010CN101670013A Production method of fenugreek foot bacteriostatic spray
03/17/2010CN101670000A Compound acne-removing Chinese herbal extract and preparation method therefor
03/17/2010CN101669999A External traditional Chinese medicine preparation for treating fungal dermatopathy
03/17/2010CN101669998A Corydalis saxicola pill and preparation method thereof
03/17/2010CN101669986A Compound gel preparation containing sophora alopecuroide oil
03/17/2010CN101669983A Drug for treating alopecia areata and preparation method thereof
03/17/2010CN101669968A Particle blood platelet dry powder preparation and preparation method thereof and application thereof
03/17/2010CN101669967A Silver-containing wound care device, composition thereof, and method of producing same
03/17/2010CN101669923A Adhesive patch for protecting and treating viral cutaneous lesions
03/17/2010CN101669913A Levocetirizine dihydrochloride granule and preparation and detection methods thereof
03/17/2010CN100594032C Oral and external remedy for curing psoriasis
03/17/2010CN100594030C Externally-used Chinese traditional medicine ointment for treating paronychia
03/17/2010CN100594028C Composition containing chondroitin sulfate zinc and its application
03/17/2010CN100594027C Percutaneous medicine of strychnine, toxiferine, securinine and salt thereof
03/16/2010US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678885 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
03/16/2010US7678834 Substituted 4-aminocyclohexanol compounds
03/16/2010US7678810 activin receptor-like kinase 5 (ALK5) (which is a TGF- beta type I receptor) inhibitor ; glomerulonephritis, diabetic nephropathy, hepatic fibrosis, liver cirrhosis, pulmonary fibrosis, or alopeciarosis; hair growth stimulant
03/16/2010US7678792 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent
03/16/2010US7678552 Method for selecting therapeutic agents for cancer treatment
03/16/2010US7678368 Fucoidan-containing cosmetics
03/16/2010US7678366 for high penetration into fingernails and toenails; contains humectant for trapping water and liquid nail lacquer containing film forming agent
03/16/2010CA2639525A1 Topical composition for the protection and/or treatment of radiation related skin damages
03/16/2010CA2493277C Antipyrotic and method of manufacturing the same
03/16/2010CA2459981C For producing biologically active products
03/16/2010CA2438646C Pyrimidine derivatives for inhibition of cell-proliferation
03/16/2010CA2436724C Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn)
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2395121C Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2296334C A dispensing device and method for forming material
03/11/2010WO2010028254A2 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
03/11/2010WO2010027802A2 Methods for treating diabetic wounds
03/11/2010WO2010027603A2 Compositions comprising solid particles encapsulated in a cross-linked silicone matrix, and methods of making the same
03/11/2010WO2010027189A2 A new use for homoisoflavanone or a salt thereof
03/11/2010WO2010027040A1 HAIR GROWTH PROMOTING AGENT CONTAINING 15,15-DIFLUOROPROSTAGLANDIN F2α DERIVATIVE AS ACTIVE INGREDIENT
03/11/2010WO2010027010A1 Pharmaceutical solid preparation having active ingredients separated by boundary therein
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026993A1 Method for improving absorbability of preparation, and preparation having improved absorbability
03/11/2010WO2010026873A1 Novel compound ceramidastin, process for production thereof, and use thereof
03/11/2010WO2010026609A1 Composition for preventing or treating alopecia
03/11/2010WO2010026596A2 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses
03/11/2010WO2010026325A1 Use of an n-acyl amino acid selected from among n-palmitoyl alanine, n-palmitoyl glycine, n-palmitoyl isoleucine, and n-cocoyl alanine as an active agent controlling the proportion of basal keratinocytes of the human skin epidermis and expressing the nuclear form of surviving, and anti-aging cosmetic composition comprising same
03/11/2010WO2010007175A3 Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them
03/11/2010WO2009158248A3 Method and compositions for improving skin and body appearance
03/11/2010WO2009150214A3 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
03/11/2010WO2009138582A3 Use of a composition containing 7-dehydrocholesterol or a natural extract of a vegetable or animal microorganism
03/11/2010WO2009090394A3 Composition containing capsicum for treating a skin disorder
03/11/2010US20100063152 Method and Topical Formulation for Treating Localized Edema
03/11/2010US20100063144 Compounds and uses thereof
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063070 Combination for use in the treatment of inflammatory disorders
03/11/2010US20100063067 Cyclic derivatives as modulators of chemokine receptor activity
03/11/2010US20100063065 Thiophene derivatives as ppar agonists i
03/11/2010US20100063015 Skin-care preparations containing mupirocin and betamethasone dipropionate
03/11/2010US20100063008 Gelatinous elastomer compositions
03/11/2010US20100062992 Salts of 5-Azacytidine
03/11/2010US20100062085 Treatment of damaged skin
03/11/2010US20100062055 Lipid-based nitric oxide donors
1 ... 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 ... 1065